Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Psychotropic medications may cut risk of violent reoffending

Research

A study by the University of Oxford, looking at rates of violent re-offences among former prisoners in Sweden, has shown that prescribing psychotropic medications can cut the risk of violent reoffending.

© spring23 - Shutterstock

Image courtesy of Shutterstock

Prescribing ex-prisoners psychotropic medications after release is associated with a decrease in reoffending, according to a new study led by the University of Oxford.

The researchers looked at released prisoners from across Sweden between 2005 and 2010, who were prescribed antipsychotics, psychostimulants and drugs for addictive disorders, and followed until end of 2013. By comparing the periods when they were and were not prescribed these medications, the researchers were able to show a drop in the rate of violent reoffending while they were receiving treatment.

Read more

Similar stories

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

Cognitive behavioural therapy: we discovered a data gap on its effectiveness for different ethnic groups

General Research

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.

New study shows overwhelming public support for donating vaccines to low-income countries

Coronavirus COVID-19 General Research

A survey led by Nuffield Department of Population Health's Health Economics Research Centre has found that most people in high-income countries support donating some of their country’s COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.